Latest News
Week ahead: Ceasefire negotiations, US jobs report in focus
The coming week's focus will continue to be on the war in Ukraine with ceasefire negotiations reportedly set to resume on Monday.
Europe close: Stocks edge higher as EU and US sign LNG deal
European shares rose on Friday as investors cheered a deal between the European Union and US to increase gas exports to the bloc and reduce reliance on Russian energy.
London close: Stocks finish positive despite gloomy outlook
London stocks managed a positive close on Friday, despite disappointing retail sales data and a gloomy consumer confidence survey released earlier.
Treasury's Yellen pushes back on need for sanctions on China to deter against aid for Russia
America's Secretary of the Treasury argued against imposing sanctions on China as a partner to Russia.
Weekly review
The FTSE 100 ended the week 78. 62 points higher, closing at 7,483. 35 on Friday.
FTSE 250 movers: Drax powers ahead on upgrade; housebuilders hit
London’s FTSE 250 was up 0. 4% at 20,981. 04 in afternoon trade on Friday.
Broker tips: FeverTree Drinks, B&M European Value Retail, HomeServe
Analysts at Berenberg lowered their target price on drinks maker FeverTree from 2,600. 0p to 2,250. 0p on Friday after the group lowered its full-year underlying earnings guidance.
Morgan Stanley prefers Tesco over Sainsbury, says it's best placed for rising inflationary environment
Analysts at Morgan Stanley reiterated their preference for shares of Tesco over rival Sainsbury, arguing that the former was better placed to adapt to the expected higher food inflation and to protect its margins.
US consumer confidence slips amid as accelerating inflation hits finances, economic outlook
Consumer confidence in the US continued to slip lower in March as concern about mounting inflation dragged on American's outlook for their own finances and the wider national economy.
US open: Stocks mixed after EU and US strike deal to ween off Russian energy
Wall Street stocks were mixed early on Friday after the European Union struck a deal with the US in an effort to lower its Russian energy usage.
US pre-open: Futures higher as US strikes energy deal with EU
Wall Street futures were in the green ahead of the bell on Friday after the European Union struck a deal with the US in an effort to lower its Russian energy usage.
FTSE 100 movers: Rolls-Royce rallies; B&M hit by downgrade
London’s FTSE 100 was up 0. 4% at 7,500. 51 in afternoon trade on Friday.
Director dealings: Jardines ex-MD makes $26m 'family estate' deals
Jardine Matheson hogged the limelight on both sides of director dealings on Friday, as its former managing director was attached to a disposal and a purchase worth more than $26m.
Alliance Pharma upbeat on prospects for US acquisitions
Alliance Pharma completed the acquisition of both ‘ScarAway’ - the largest silicone-based scar treatment brand in the US - and the rights to sell ‘Kelo-cote’ in the American retail consumer market in the US on Friday.
China's Sinopec suspends talks on Russia projects - report
China's state-run Sinopec Group has reportedly suspended talks for a major petrochemical investment and a gas marketing venture in Russia.
Berenberg lowers target price on Fevertree
Analysts at Berenberg lowered their target price on drinks maker Fevertree from 2,600. 0p to 2,250. 0p on Friday after the group lowered its full-year underlying earnings guidance.
Minoan appoints chairman to subsidiary Crete resort developer
Minoan announced the appointment of George Mergos as chairman of its wholly-owned subsidiary Loyalward on Friday, which owns the Itanos Gaia project in Crete.
Co-op Group finance chief to step up as interim CEO
The Co-op announced on Friday that group chief executive officer Steve Murrells will step down following its annual general meeting in May.
Advanced Oncotherapy raises £2m for proton therapy development
Proton therapy technology developer Advanced Oncotherapy announced an equity fundraise of £2m on Friday, to fund itself along its revised timetable for the development of the ‘LIGHT’ cancer therapy system.
Credit Suisse downgrades B&M European Value Retail
Credit Suisse downgraded discount retailer B&M European Value Retail to ‘neutral’ from ‘outperform’ on Friday and cut the price target to 600p from 675p, noting that the shares have consistently outperformed UK retail over the past year.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.
The value of investments can fall and you may get back less than you invested.